{"title":"> 200ml腺体梗阻性良性前列腺增生的治疗。","authors":"Christopher E Kelly","doi":"10.3909/riu0795","DOIUrl":null,"url":null,"abstract":"A 78-year-old man presented with longstanding and progressive lower urinary tract symptoms (LUTS). Predominant symptoms were decreased flow, sensation of incomplete emptying, and nocturia x1-3. The patient’s LUTS progressed despite his being on a high-dose alphablocker and a 5-alpha reductase inhibitor. He had one episode of acute urinary retention and one urinary tract infection in the past 6 months. His American Urological Association Symptom Score (AUASS) was 24.","PeriodicalId":21185,"journal":{"name":"Reviews in urology","volume":"20 1","pages":"43-45"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003305/pdf/RIU020001_043.pdf","citationCount":"0","resultStr":"{\"title\":\"Management of Obstructive Benign Prostatic Hyperplasia With a >200 mL Gland.\",\"authors\":\"Christopher E Kelly\",\"doi\":\"10.3909/riu0795\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 78-year-old man presented with longstanding and progressive lower urinary tract symptoms (LUTS). Predominant symptoms were decreased flow, sensation of incomplete emptying, and nocturia x1-3. The patient’s LUTS progressed despite his being on a high-dose alphablocker and a 5-alpha reductase inhibitor. He had one episode of acute urinary retention and one urinary tract infection in the past 6 months. His American Urological Association Symptom Score (AUASS) was 24.\",\"PeriodicalId\":21185,\"journal\":{\"name\":\"Reviews in urology\",\"volume\":\"20 1\",\"pages\":\"43-45\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003305/pdf/RIU020001_043.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3909/riu0795\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3909/riu0795","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Management of Obstructive Benign Prostatic Hyperplasia With a >200 mL Gland.
A 78-year-old man presented with longstanding and progressive lower urinary tract symptoms (LUTS). Predominant symptoms were decreased flow, sensation of incomplete emptying, and nocturia x1-3. The patient’s LUTS progressed despite his being on a high-dose alphablocker and a 5-alpha reductase inhibitor. He had one episode of acute urinary retention and one urinary tract infection in the past 6 months. His American Urological Association Symptom Score (AUASS) was 24.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
